Ken is a biotech entrepreneur with 25 years of experience in the field. Ken’s journey has seen him navigate through target discovery at the BC Cancer Research Center, preclinical research at Inimex Pharmaceuticals, clinical research management at BC Clinical Research, and business development roles at Helios & iProgen. He held a certification from RAPS in US Regulatory Affairs and was designated as a Clinical Research Professional by the Society of Clinical Research. Ken holds B.Sc. from UBC and MBA from the Richard Ivey School of Business.

Leo brings over two decades of expertise in protein engineering and protein delivery technology, the founding scientist at iProgen has contributed immensely to our patent portfolio as a co-inventor; Leo spearheads all technological innovation at iProgen; completed post-doctoral work at Natalie Strynadka’s lab at UBC.  Leo immigrated to Canada from Taiwan in his childhood and graduated with Ph.D., from McGill University with the Governor General’s Gold Medal.

Mr. Wood has over 30 years of experience in management of both early and late stage companies in North America and the U.K. and has over 18 years of experience in the biopharmaceutical industry, where he has overseen several M&A transactions and numerous financings. Prior to joining ESSA, Mr. Wood was Head of Finance, Secretary and Treasurer at Celator Pharmaceuticals Inc., now a subsidiary of Jazz Pharmaceuticals. He received a B.Sc. in Biology from Queen’s University, an M.B.A. from University of Western Ontario and holds a CPA, CMA accounting designation.

Ranjani is a seasoned biotechnology professional with more than 16 years of industry experience in research and operational management. Her portfolio includes, but not limited to, leading internal research projects and external collaborations, patent contributions and managing and mentoring staff. Her scientific expertise includes cell line development and recombinant protein production (cGMP) and characterization, antibody and ADC assay development.

Nigel has 18 years of experience in corporate and business development across the public and private sectors including Health Canada, Deloitte, and Royal Bank of Canada. As a seasoned business development expert, Nigel has worked across a variety of roles, including as a Business Transformation Consultant, Business Architect, and Project Manager. His key areas of expertise include new business strategy, design and implementation all supported though performance management. Nigel holds a B.Sc. in Biology from the University of British Columbia and an MBA from the Richard Ivey School of Business.

Michael is a Cambridge University educated corporate lawyer, entrepreneur, investor and philanthropist. Previously, he was civil litigator at McCarthy Tetrault and Robertson, Peck, Thompson, Casilio, Vancouver. Formerly, he was also Advisor to the House of Commons Standing Committee on Transport, Ottawa.